Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Pradines

Showing results (81-90 of 199) with videos related to

Pageof 20
Sort By:
Phytotherapy Research : PTR|July 14, 2017
Stephanine from Stephania venosa (Blume) Spreng Showed Effective Antiplasmodial and Anticancer Activities, the Latter by Inducing Apoptosis through the Reverse of Mitotic ExitPhuong Mai Le, Vandana Srivastava, Thanh Tam Nguyen, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2008
First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in ComorosHelene Savini, Hervé Bogreau, Lionel Bertaux, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2008
In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparumMaud Henry, Sébastien Briolant, Albin Fontaine, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2015
Molecular Markers and In Vitro Susceptibility to Doxycycline in Plasmodium falciparum Isolates from ThailandTiphaine Gaillard, Kanlaya Sriprawat, Sébastien Briolant, et al.
Malaria Journal|September 18, 2015
Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycyclineTiphaine Gaillard, Nathalie Wurtz, Sandrine Houzé, et al.
Malaria Journal|May 26, 2010
Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparumVéronique Parquet, Maud Henry, Nathalie Wurtz, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
Proveblue (methylene blue) as an antimalarial agent: in vitro synergy with dihydroartemisinin and atorvastatinJérôme Dormoi, Aurélie Pascual, Sébastien Briolant, et al.
Biology|February 23, 2024
Long-Read Sequencing and <i>De Novo</i> Genome Assembly Pipeline of Two <i>Plasmodium falciparum</i> Clones (<i>Pf</i>3D7, <i>Pf</i>W2) Using Only the PromethION Sequencer from Oxford Nanopore Technologies without Whole-Genome AmplificationOcéane Delandre, Ombeline Lamer, Jean-Marie Loreau, et al.
Malaria Journal|February 15, 2011
In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of CongoSébastien Briolant, Stéphane Pelleau, Hervé Bogreau, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2017
Plasmodium falciparum Recrudescence Two Years after Treatment of an Uncomplicated Infection without Return to an Area Where Malaria Is EndemicDenis Malvy, Marylin Torrentino-Madamet, Coralie L'Ollivier, et al.
Pageof 20

Showing results (81-90 of 199) with videos related to

Sort By:
Pageof 20
Phytotherapy Research : PTR|July 14, 2017
Stephanine from Stephania venosa (Blume) Spreng Showed Effective Antiplasmodial and Anticancer Activities, the Latter by Inducing Apoptosis through the Reverse of Mitotic ExitPhuong Mai Le, Vandana Srivastava, Thanh Tam Nguyen, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2008
First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in ComorosHelene Savini, Hervé Bogreau, Lionel Bertaux, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2008
In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparumMaud Henry, Sébastien Briolant, Albin Fontaine, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2015
Molecular Markers and In Vitro Susceptibility to Doxycycline in Plasmodium falciparum Isolates from ThailandTiphaine Gaillard, Kanlaya Sriprawat, Sébastien Briolant, et al.
Malaria Journal|September 18, 2015
Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycyclineTiphaine Gaillard, Nathalie Wurtz, Sandrine Houzé, et al.
Malaria Journal|May 26, 2010
Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparumVéronique Parquet, Maud Henry, Nathalie Wurtz, et al.
Antimicrobial Agents and Chemotherapy|March 7, 2012
Proveblue (methylene blue) as an antimalarial agent: in vitro synergy with dihydroartemisinin and atorvastatinJérôme Dormoi, Aurélie Pascual, Sébastien Briolant, et al.
Biology|February 23, 2024
Long-Read Sequencing and <i>De Novo</i> Genome Assembly Pipeline of Two <i>Plasmodium falciparum</i> Clones (<i>Pf</i>3D7, <i>Pf</i>W2) Using Only the PromethION Sequencer from Oxford Nanopore Technologies without Whole-Genome AmplificationOcéane Delandre, Ombeline Lamer, Jean-Marie Loreau, et al.
Malaria Journal|February 15, 2011
In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of CongoSébastien Briolant, Stéphane Pelleau, Hervé Bogreau, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2017
Plasmodium falciparum Recrudescence Two Years after Treatment of an Uncomplicated Infection without Return to an Area Where Malaria Is EndemicDenis Malvy, Marylin Torrentino-Madamet, Coralie L'Ollivier, et al.
Pageof 20